Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence.

[1]  Amartya Sen,et al.  Human Development Index , 2003 .

[2]  S. Hutchinson,et al.  Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. , 2019, The lancet. HIV.

[3]  L. Degenhardt,et al.  Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done? , 2018, Addiction.

[4]  H. Hagan,et al.  Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis , 2017, Addiction.

[5]  S. Hewitt,et al.  2017 , 2017, Les 25 ans de l’OMC: Une rétrospective en photos.

[6]  J. Leung,et al.  Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review , 2017, The Lancet. Global health.

[7]  J. Leung,et al.  Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review , 2017, The Lancet. Global health.

[8]  J. Montaner,et al.  HIV and the criminalisation of drug use among people who inject drugs: a systematic review. , 2017, The lancet. HIV.

[9]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[10]  Christopher M. Jones,et al.  County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States , 2016, Journal of acquired immune deficiency syndromes.

[11]  K. Stone.  Global state of harm reduction 2016. , 2016 .

[12]  R. Hogg,et al.  Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs , 2016, Current opinion in HIV and AIDS.

[13]  Michael W. Spiller,et al.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. , 2016, The New England journal of medicine.

[14]  Phillip L. Marotta,et al.  A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011. , 2016, The International journal on drug policy.

[15]  L. Abu-Raddad,et al.  Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa , 2015, AIDS.

[16]  C. Beyrer,et al.  Threading the Needle--How to Stop the HIV Outbreak in Rural Indiana. , 2015, The New England journal of medicine.

[17]  Jonathan E. Suk,et al.  National Income Inequality and Declining GDP Growth Rates Are Associated with Increases in HIV Diagnoses among People Who Inject Drugs in Europe: A Panel Data Analysis , 2015, PloS one.

[18]  A. Abagiu,et al.  HIV/AIDS among injecting drug users in Romania , 2015 .

[19]  Janet J. Hamilton,et al.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Nguyen Le Minh,et al.  Community-Level Income Inequality and HIV Prevalence among Persons Who Inject Drugs in Thai Nguyen, Vietnam , 2014, PloS one.

[21]  M. Hellard,et al.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. , 2014, International journal of epidemiology.

[22]  A. Pharris,et al.  Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. , 2014, The International journal on drug policy.

[23]  A. Hatzakis,et al.  Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study , 2013, PloS one.

[24]  A. Abdul-Quader,et al.  High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review , 2013, BMC Public Health.

[25]  P. Vickerman,et al.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[26]  Kate Shannon,et al.  Structural Violence and Structural Vulnerability Within the Risk Environment: Theoretical and Methodological Perspectives for a Social Epidemiology of HIV Risk Among Injection Drug Users and Sex Workers , 2011 .

[27]  T. Hallett,et al.  HIV and risk environment for injecting drug users: the past, present, and future , 2010, The Lancet.

[28]  M. Kretzschmar,et al.  Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. , 2010, Addiction.

[29]  S. Friedman,et al.  HIV among injection drug users in large US metropolitan areas, 1998 , 2005, Journal of Urban Health.

[30]  H. Morgenstern,et al.  Ecologic studies in epidemiology: concepts, principles, and methods. , 1995, Annual review of public health.

[31]  Index , 1984, Canadian Yearbook of international Law/Annuaire canadien de droit international.